Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Equity Income (2023 - 2025)

Historic Equity Income for Rallybio (RLYB) over the last 3 years, with Q2 2025 value amounting to -$287000.0.

  • Rallybio's Equity Income rose 4106.78% to -$287000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was -$1.3 million, marking a year-over-year increase of 4616.02%. This contributed to the annual value of -$2.2 million for FY2024, which is 970.11% down from last year.
  • Rallybio's Equity Income amounted to -$287000.0 in Q2 2025, which was up 4106.78% from -$587000.0 recorded in Q1 2025.
  • In the past 5 years, Rallybio's Equity Income registered a high of -$217000.0 during Q2 2023, and its lowest value of -$685000.0 during Q1 2024.
  • In the last 3 years, Rallybio's Equity Income had a median value of -$575000.0 in 2023 and averaged -$515400.0.
  • In the last 5 years, Rallybio's Equity Income tumbled by 12442.4% in 2024 and then soared by 4106.78% in 2025.
  • Over the past 3 years, Rallybio's Equity Income (Quarter) stood at -$613000.0 in 2023, then increased by 29.85% to -$430000.0 in 2024, then soared by 33.26% to -$287000.0 in 2025.
  • Its last three reported values are -$287000.0 in Q2 2025, -$587000.0 for Q1 2025, and -$430000.0 during Q4 2024.